We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
肝细胞癌免疫治疗研究进展.
- Authors
朱丽珍; 许晓磊; 阿卜杜萨拉木·艾尼; 王小娟; 周虎; 汤睿; 樊海宁; 卢倩
- Abstract
Hepatocellular carcinoma(HCC) has an insidious onset, and most patients are in the advanced stage when attending the hospital and thus lose the opportunity for radical surgical resection, which results in the poor prognosis of patients. With the development of clinical treatment, the treatment of advanced HCC has gradually transitioned from the relatively single and limited treatment options in the past to the new model of comprehensive treatment. In recent years, immunotherapy, represented by immune checkpoint inhibitors(ICIs), has become widely used in clinical practice. At present, a number of clinical studies have been conducted for immunotherapy combined with local and targeted antitumor therapy, and in particular, ICIs combined with targeted therapy have become a research hotspot in the field of HCC treatment. This article reviews the research advances in immunotherapy for the treatment of HCC.
- Publication
Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi, 2023, Vol 39, Issue 5, p1197
- ISSN
1001-5256
- Publication type
Article
- DOI
10.3969/j.issn.1001-5256.2023.05.031